Carbohydrate metabolism changes in cystic fibrosis

Journal of Pediatric Endocrinology and Metabolism

Volumn 20, Issue 5, 2007, Pages 621-632

  Domínguez García, Ángela ^a,d   Quinteíro González, Sofía ^a   Peña Quintana, Luis ^a   Ramos Macias, Leticia ^a   Quintana Martel, Mercedes ^b   Saavedra Santana, Pedro ^c  

^a Paediatric Clinic   (Spain)

^b Hospital Universitario Materno Infantil de Canarias   (Spain)

^c UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^d NONE   (Spain)

Author keywords

Beta cell function; Cystic fibrosis; Diabetes mellitus; Genotype; Impaired glucose tolerance; Insulin resistance; Oral glucose tolerance test

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DIABETES MELLITUS; DISORDERS OF CARBOHYDRATE METABOLISM; FEMALE; GENE MUTATION; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; ORAL GLUCOSE TOLERANCE TEST; PANCREAS FUNCTION; PANCREAS ISLET BETA CELL; PREVALENCE;

EID: 34250705350     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2007.20.5.621     Document Type: Article

References (47)

1. Hardin D, Moran A, Diabetes mellitus in cystic fibrosis. Endocrinol Metab Clin N Am 1999; 28: 787-800.
2. Riggs A, Seaquist E, Moran A. Guidelines for the diagnosis and therapy of diabetes mellitus in cystic fibrosis. Curr Opin Puhn Med 1999; 5: 378-382.
3. Moran A, Hardin D, Rodman D, Allen HF, Beal RJ, Borowitz D. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus. A consensus confeence report. Diabetes Res Clin Pract 1999; 45: 61-73.
4. Navarro H, Kolbach M, Repetto G, Guiraldes E, Harris P, Foradori A, Paggi H, Sanchez L. Correlation between phenotype and genotype in a group of patients with cystic fibrosis. Rev Med Child 2002; 130: 475-481.
5. Koch C, Cuppens H, Rainisio M, Madessani U, Harms HK, Hodsosn ME, Mastella G, Navarro J, Strandvik B, McKenzie SG. European Epidemiologic Registry of Cystic Fibrosis (ERCF): Comparison of major disease manifestations between patients with different classes of mutations. Pediatr Pulmonol 2001; 31: 1-12.
6. Allen HF, Gay EC, Klingensmith GJ, Hamman RF. Identification and treatment of cystic fibrosis related diabetes. Diabetes Care 1998; 21: 943-948.
7. Cystic Fibrosis Foundation National Patient Registry: 1997 Annual Data Report. Bethesda, MD: Cystic Fibrosis Foundation, 1998.
8. Moran A, Doherty L, Wang X, Thomas W. Abnormal glucose metabolism in cystic fibrosis, J Pediatr 1998; 133: 10-17.
9. Lanng S, Thorsteinsson F, Lund-Andersen C, Nerup J, Schiotz PO, Koch C. Diabetes mellitus in Danish cystic fibrosis patients. Prevalence and late diabetic complications. Acta Paediatr 1994; 83: 72-77.
10. Lanng S, Hansen A, Thorsteinsson B, Neruo J, Koch C. Glucose tolerance in cystic fibrosis: a five year prospective study. BMJ 1995; 311: 655-659.
11. Yudkin JS, Alberti KG. Impaired glucose tolerance. BMJ 1990; 301: 397-402.
12. Rolon HA, Benali K, Munk A, Navarro J, Clement A, Tubiana Rufi N, Czernichow P, Polack M. Cystic fibrosis related diabetes mellitus: clinical impact of prediabetes and effects of insulin terapy. Acta Paediatr 2001; 90: 860-867.
13. Lanng S, Thorsteeinsson B, Nerup J, Koch C. Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections. Acta Paediatr 1994; 83: 849-853.
14. Lanng S, Thorsteinssonn B, Nerup J, Koch C. Diabetes mellitus in cystic fibrosis: a ten year prospective study. Diabetologia 2000; 43: A27.
15. Brasfield D, Hicks G, Soong S, Tiller RE. The chest roentgenogram in cystic fibrosis: a new scoring system. Pediatrics 1979; 63: 24-29.
16. Elks ML. Oral glucose tolerance test. Diabetes Care 1996; 19: 271.
17. Barrio Castellanos R, Cos Blanco A, García García E, Gussinyé Cañadell M, Merino Torres JF, Muñoz Calvo MT. Consenso sobre diagnóstico y tratamiento de las alteraciones del metabolismo de los carbohidratos en la fibrosis quística. An Esp Pediatr 2000; 53: 573-579.
18. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183-1197.
19. Haffner S, Stern M, Hazuda H, Pugh J, Patterson J. Hyperinsulinemia in a population at high risk for non-insulin dependent diabetes mellitus. N Engl J Med 1986; 315: 220-224.
20. Wareham NJ, Philips DI, Byrne CD, Hales CN. The 30 minute insulin incremental response in an oral glucose tolerance test as a measuree of insulin secretion. Diabet Med 1995; 12: 931.
21. Invitti C, Guzzaloni G, Gilardini L, Morabito F, Viberti G. Prevalence and concomitants of glucose intolerance in European obese children and adolescents. Diabetes Care 2003; 26: 118-124.
22. Radziuk J. Insulin sensitivity and its measurement: structural commonalities among the methods. J Clin Endocrinol Metab 2000; 85: 4426-4433.
23. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22: 1462-1470.
24. Matthew DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
25. Lanng S. Glucose intolerance in cystic fibrosis patients. Paediatr Respir Rev 2001; 2: 253-259.
26. Solomon MP, Wilson DC, Corey M, Kalnis D, Zielenski J, Tsui LC, Pencherz P, Durie P, Sweezey NB. Glucose intolerance in children with cystic fibrosis. J Pediatr 2003; 142: 128-132.
27. Nousia Arvanitakis S, Galli Tsinopoulou A, Karamouzis M. Insulin improves clinical status of patients with cystic fibrosis related diabetes mellitus. Acta Paediatr 2001; 90: 515-519.
28. Garagorri JM, Rodriquez G, Ros L, Sanchez A. Early detection of impaired glucose tolerance in patients with cystic fibrosis and predisposition factors. J Pediatr Endocrinol Metab 2001; 14: 53-60.
29. Yung B, Kemp M, Hooper J, Hodson ME. Diagnosis of cystic fibrosis related diabetes: a selective approach in performing the glucose tolerance test based on a combination of clinical and biochemical criteria. Thorax 1999; 54: 40-43.
30. García García E, Lopez Siguero JP, Olveira C, Perez Ruiz E, García JM, Perez Frias J, Martinez Valverde A. Carbohydrate metabolic changes in cystic fibrosis. Med Clin 1999; 113: 601-603.
31. Moran A. Diagnosis, screening and management of cystic fibrosis related diabetes. Curr Diab Rep 2002; 2: 111-115.
32. Lanng S, Thorsteinsson F, Erichsen G, Nerup J, Koch C. Glucose tolerance in cystic fibrosis. Arch Dis Child 1991; 66: 612-616.
33. Vazquez C. Diagnosis of the cystic fibrosis. An Esp Pediatr 1999; 50: 431-438.
34. Rosenstein BJ. Genotype-phenotype correlation in cystic fibrosis. Lancet 1994; 343: 746-747.
35. Cucinotta D, De Luca F, Scoglio R, Lombardo F, Sferlazzas C, Di Bededetto A, Magazzu G, Raimondo G, Arrigo T. Factors affecting diabetes melllitus onset in cystic fibrosis: evidence from a 10 year follow up study. Acta Paediatr 1999; 88: 389-393.
36. Rosenecker J, Eichler I, Kuhn L, Harms K, Von der Hardt J. Genetic determinationn of diabetes mellitus in patients with cystic fibrosis. J Pediatr 1995; 127: 441-443.
37. Srider MK. Nutrition and lung health. Proc Nutr Soc 1999; 58: 303-308.
38. De Schepper J, Dab I, Derde MP, Loeb H. Oral glucose tolerance testing in cystic fibrosis: correlations with clinical parameters and glycosylated hemoglobin determinations. Eur J Pediatr 1991; 150: 403-406.
39. Milla C, Warwick W, Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med 2000; 162: 891-895.
40. Moran A, Pyzdrowski K, Weinreb J, Khan BB, Smith SA, Adams KS, Seaquist CR. Insulin sensitivity in cystic fibrosis. Diabetes 1994; 43: 1020-1026.
41. Austin A, Kalhan SC, Orenstein D, Nixon P, Arslanian S. Roles of insulin resistance and beta cell disfunction in the pathogenesis of glucose intolerance in cystic fibrosis. J Clin Endocrinol Metab 1994; 79: 80-85.
42. Lanng S, Thorsteinsson B, Roder ME, Nerup J, Koch C. Insulin sensitivity and insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance. Clin Endocrinol 1994; 41: 217-223.
43. Ripa P, Robertson I, Cowley D, Harris M, Brant I, Cotterill A. The relationship between insulin secretion, the insulin like growth factor axis and growth in children with cystic fibrosis. Clin Endocrinol 2002; 56: 383.
44. Yung B, Noormohamed, Kemp M, Hooper J, Lant AF, Hodson ME. Cystic fibrosis related diabetes: the role of peripheral insulin resistance and beta cell dysfunction. Diabet Med 2002; 19: 221-226.
45. Hardin DS, LeBlanc A, Lukenbaugh S, Seilheimer DK. Insulin resistance is associated with decrease clinical status in cystic fibrosis. J Pediatr 1997; 130: 948-946.
46. Cuccinotta D, Conti Nabali S, Arrigo T, Di Benedetto A, Magazzu G, Di Cesare E. Beta cell function, peripheral sensitivity to insulin and islet cell autoinmunity in cystic fibrosis patients with normal glucose tolerance. Horm Res 1990; 34: 33-38.
47. Cucinotta D, Luca F, Gigante A, Arrigo T, Di Benedetto A, Tedeschii A. No changes in insulin sensitivity in cystic fibrosis patients with different degrees of glucose tolerance: an epidemiological and longitudinal study. Eur J Endocrinol 1994; 130: 253-258.